Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
23 May, 2019 16:33 IST
Lupin receives 2 USFDA observations for Goa manufacturing facility
Source: IRIS | 11 Feb, 2019, 10.34AM
Comments  |  Post Comment

Pharma major Lupin announced the completion of the United States Food and Drug Administration (U.S. FDA) inspection at its Goa manufacturing facility. The inspection was carried out between January 28 to February 8, 2019.

The inspection at the Goa facility closed with 2 observations. The observations are procedural in nature and the company is confident of addressing them satisfactorily.

The stock had underperformed the market over the past one month till Feb. 08, 2019, rising 0.10% compared with the Sensex's 1.57% rise. It underperformed the market in past one quarter, declining 3.60% as against 3.71% rise in the Sensex.

Shares of the company declined Rs 4.4, or 0.53%, to trade at Rs 826.00. The total volume of shares traded was 12,465 at the BSE (9.34 a.m., Monday).

Lupin Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Security Code type    into this box
Company Update
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer